A blended strain gummy produced in Ontario by SPOT in the Cannabis Edibles category with 48% Lower THC* potency at 0.9mg and Nominal CBD* content at 0.1mg. Includes 48% Higher CBG* content at 3.6mg (* based on average potencies for Gummies).
Based on limited terpene and strain data, we find Gooseberry to have a 2/10 score for aid with inflammation** including help with infection, and overall product score (ePS) of 3/10 when compared to products in the same category.
The chart below provides an overview of potencies for each major product category, with red vertical bars for THC, THCv averages and green for CBD, including averages for minor cannabinoids CBG, CBN and CBC, when present.
These indicators are also displayed on all individual CSMeter readings, showing that products' category average for a simplified visual reference.